| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3284167 | Clinical Gastroenterology and Hepatology | 2009 | 7 Pages |
Abstract
Daily oral fluoroquinolone prophylaxis reduces the risk of development of first episode of SBP and mortality in cirrhotic patients with low total protein in the ascitic fluid. Fluoroquinolones might be advisable for the primary prophylaxis of SBP in selected high-risk patients with cirrhosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Rohit Loomba, Robert Wesley, Andrew Bain, Gyorgy Csako, Frank Pucino,